1

Vestar Capital Partners and Management of Sheridan Healthcare to Take the 
Company Private

Sheridan Healthcare Shareholders to Receive $9.25 Per Share In Cash

     NEW YORK and HOLLYWOOD, Fla. (March 25, 1999) Sheridan Healthcare, Inc. 
(Nasdaq/NM: SHCR) today announced the signing of a definitive merger agreement 
between the Company and an investor group led by Vestar Capital Partners and 
Sheridan Healthcare senior management. Sheridan Healthcare is a physician 
practice management company primarily providing anesthesia and women's health 
services to patients in Florida and Texas. The management investors are led by 
Dr. Mitchell Eisenberg and Dr. Lewis Gold, the current Chief Executive 
Officer and Executive Vice President of the Company, respectively.
Under the terms of the agreement, the investor group will offer Sheridan 
Healthcare shareholders $9.25 per share in cash for all outstanding common 
shares in a tender offer to commence within the next five business days. 
Including debt and other obligations of the Company, and costs expected to be 
incurred in connection with the acquisition, the total value of the transaction 
is approximately $155 million. NationsBank, N.A. and its affiliates, the 
Companys existing lender, have committed to provide $75 million in bank 
financing to fund the acquisition. Through Vestar Capital Partners III, L.P., 
Vestar has committed to provide the remaining funds necessary to complete the 
transaction. NationsBank has also committed to provide a $50 million credit 
facility to fund the Companys long-term future growth and expansion.     

Sheridan Healthcare entered into the merger agreement following a unanimous 
recommendation by the Companys Board of Directors. The Board received fairness 
opinions from Bowles Hollowell Conner, a division of First Union Capital 
Markets Corp., and Salomon Smith Barney Inc., who, as previously announced, had 
been retained to assist the Company in exploring strategic alternatives.

Dr. Eisenberg stated, "Sheridan Healthcare has engaged in an extensive process, 
with the assistance of its financial advisors, in soliciting and evaluating 
third party interest in a sale of the Company. Our new partnership with Vestar 
provides Sheridan Healthcare with a much needed capital base to achieve its 
longer-term growth objectives. It also importantly provides Sheridan 
Healthcares community of employees, physician partners, hospitals and payors 
with a stronger sense of stability and financial backing."
   2
Jim Elrod, Managing Director of Vestar, said, "Vestar believes that physicians,
like those affiliated with Sheridan Healthcare, will always be at the center of
quality healthcare. Sheridan Healthcare has an enviable record of delivering
real value to its physicians while serving a growing patient base in very
attractive markets. We're extremely pleased to be investing with Dr. Eisenberg,
Dr. Gold, and the rest of the management team in the business they've built."

Following completion of the tender offer, Vestar will be entitled to designate a
majority of the Board of Directors of Sheridan Healthcare. The parties will
complete a second-step cash merger at $9.25 per share as promptly as practicable
following completion of the tender offer. The transaction is subject to a
variety of conditions, including receipt of at least a majority of the voting
stock in the tender offer, shareholder approval, financing and regulatory
approvals.

Sheridan Healthcare, Inc., based in Hollywood, Fla., is a physician practice
management company which employs or manages specialist physicians providing
services at hospitals and ambulatory surgical facilities in the areas of
anesthesia, neonatology, pediatrics, emergency services, obstetrics and pain
management. In addition, it owns and operates, or manages, office-based
gynecological, obstetrical, infertility, perinatology, primary care and surgical
physician practices. The Company is affiliated with approximately 363 physicians
and 161 allied health professionals, practicing under 55 specialty service
contracts at 37 hospitals and at 28 office locations.

Vestar Capital Partners is a leading investment firm that manages more than $1
billion in equity capital and specializes in management buyouts and growth
capital investments. Vestar invests, as partners with management teams, in
high-quality, middle market companies. Since its founding in 1988, Vestar has
completed approximately 30 transactions with a total value in excess of $5
billion.

Statements contained in this press release which are not historical facts may be
considered forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. These forward-looking statements are
subject to risks and uncertainties which could cause actual results to differ
materially from those projected. Those risks and uncertainties include
fluctuations in the volume of procedures performed by the Company's affiliated
physicians, changes in the reimbursement rates for those procedures, uncertainty
about the ability to collect the appropriate fees for those procedures, the loss
of significant hospital or third-party payor relationships, and changes in the
number of patients using the Company's physician services, as well as other
risks detailed in the Company's filings with the Securities and Exchange
Commission.

###

Contact:
Kara Fitzsimmons or Gene Donati
Clark & Weinstock
212-953-2550

Jim Elrod    Vestar Capital Partners
212-351-1609
        Michael Schundler
Sheridan Healthcare, Inc. 954-986-7506